ALBANY, N.Y.--(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that Joseph Gersuk, Executive Vice President and Chief Financial Officer, will not be able to present at the RBC Capital Markets Healthcare Conference on Wednesday, March 2, 2011, due to minor injuries sustained in a recent accident.

"While Joe remains able to fulfill his daily responsibilities as CFO, he recently sustained minor injuries in an accident that prevent him from traveling," said Jan Keltjens, AngioDynamics President and CEO. "This development combined with a scheduling conflict that prevents my participation leads us to cancel our scheduled presentation at the RBC healthcare conference."

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. AngioDynamics' diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.

Company Contact:
AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
Investor Relations Contacts:
EVC Group, Inc.
Doug Sherk / Gregory Gin, 415-896-6820
dsherk@evcgroup.com
ggin@evcgroup.com
or
Media Contact:
EVC Group, Inc.
Chris Gale, 646-201-5431
cgale@evcgroup.com

Source: AngioDynamics

News Provided by Acquire Media